Tower Research Capital (TRC)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,629
Closed -$835 5989
2024
Q4
$835 Buy
3,629
+3,383
+1,375% +$778 ﹤0.01% 5156
2024
Q3
$529 Sell
246
-2,606
-91% -$5.6K ﹤0.01% 5318
2024
Q2
$14.7K Buy
2,852
+2,757
+2,902% +$14.2K ﹤0.01% 3938
2024
Q1
$508 Buy
+95
New +$508 ﹤0.01% 5460
2023
Q2
Sell
-6,584
Closed -$18K 6395
2023
Q1
$18K Sell
6,584
-5,478
-45% -$15K ﹤0.01% 3593
2022
Q4
$43K Buy
12,062
+9,410
+355% +$33.5K ﹤0.01% 2476
2022
Q3
$17K Buy
2,652
+1,718
+184% +$11K ﹤0.01% 4089
2022
Q2
$9K Sell
934
-2,343
-71% -$22.6K ﹤0.01% 4603
2022
Q1
$39K Buy
3,277
+700
+27% +$8.33K ﹤0.01% 2927
2021
Q4
$84K Buy
2,577
+1,360
+112% +$44.3K ﹤0.01% 2353
2021
Q3
$54K Sell
1,217
-1,288
-51% -$57.2K ﹤0.01% 2906
2021
Q2
$136K Sell
2,505
-945
-27% -$51.3K ﹤0.01% 2180
2021
Q1
$258K Buy
3,450
+2,087
+153% +$156K ﹤0.01% 1786
2020
Q4
$148K Sell
1,363
-683
-33% -$74.2K ﹤0.01% 1995
2020
Q3
$181K Buy
2,046
+1,213
+146% +$107K ﹤0.01% 2670
2020
Q2
$89K Buy
+833
New +$89K ﹤0.01% 2566
2019
Q4
Sell
-269
Closed -$28K 4519
2019
Q3
$28K Buy
269
+241
+861% +$25.1K ﹤0.01% 2243
2019
Q2
$3K Buy
+28
New +$3K ﹤0.01% 3180
2019
Q1
Sell
-913
Closed -$50K 4375
2018
Q4
$50K Buy
913
+811
+795% +$44.4K ﹤0.01% 1293
2018
Q3
$12K Sell
102
-82
-45% -$9.65K ﹤0.01% 2668
2018
Q2
$19K Buy
+184
New +$19K ﹤0.01% 2478
2018
Q1
Sell
-2,187
Closed -$213K 4001
2017
Q4
$213K Buy
2,187
+1,381
+171% +$135K 0.03% 543
2017
Q3
$118K Buy
+806
New +$118K 0.01% 1196
2017
Q2
Sell
-5
Closed -$1K 3683
2017
Q1
$1K Buy
5
+2
+67% +$400 ﹤0.01% 2871
2016
Q4
$0 Sell
3
-151
-98% ﹤0.01% 4505
2016
Q3
$21K Buy
+154
New +$21K ﹤0.01% 1592